4//SEC Filing
BAYS F BARRY 4
Accession 0001209191-23-012441
CIK 0001630627other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 9:00 PM ET
Size
7.2 KB
Accession
0001209191-23-012441
Insider Transaction Report
Form 4
BAYS F BARRY
Director
Transactions
- Sale
Common Stock
2023-02-21$21.74/sh−9,400$204,352→ 1,291,683 total - Sale
Common Stock
2023-02-22$21.97/sh−9,400$206,535→ 1,282,283 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.4200 to $22.0400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.7150 to $22.1800 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001183554
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 9:00 PM ET
- Size
- 7.2 KB